» Articles » PMID: 12948577

Pain Management and Symptoms of Substance Dependence Among Patients with Sickle Cell Disease

Overview
Journal Soc Sci Med
Date 2003 Sep 2
PMID 12948577
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Concerns about dependence on prescribed analgesia may compromise pain management, but there was previously little reliable evidence about substance dependence among patients with sickle cell disease (SCD). We conducted in-depth, semi-structured interviews with SCD patients in London, UK, to assess DSM-IV symptoms of substance dependence and abuse. Criteria were applied to differentiate between pain-related symptoms, which corresponded to the DSM-IV symptoms but involved analgesics used to control pain, and non-pain-related symptoms, which involved analgesic use beyond pain management. Pain-related symptoms are informative about how the pattern of recurrent acute pain in SCD may make patients vulnerable to perceptions of drug dependence. Non-pain-related symptoms are informative about more stringently defined dependence on analgesia in SCD. Inter-rater reliability was high, with mean Kappa coefficients of 0.67-0.88. The criteria could be used to assess analgesic dependence in other painful conditions. Pain-related symptoms were more frequent, accounting for 88% of all symptoms reported. When pain-related symptoms were included in the assessment, 31% of the sample met the DSM-IV criteria for substance dependence, compared with only 2% when the assessment was restricted to non-pain-related symptoms. Qualitative analysis of participants' descriptions of analgesic use showed that active coping attempts (attempts to anticipate pain and avoid hospital admissions) and awareness of dependence were themes in descriptions of both pain-related and non-pain-related symptoms. Seeking a more normal lifestyle and impaired activities were themes associated with pain-related symptoms. Psychological disturbance was a theme associated with non-pain-related symptoms. The implications are for more responsive treatment of pain in SCD and greater awareness of how patients' pain coping may be perceived as analgesic dependence. Further research could examine ways that pain-related and non-pain-related symptoms of dependence may be associated with other pain coping strategies and with the outcomes of treatment for painful episodes in hospital.

Citing Articles

Heme-Oxygenase 1 Mediated Activation of Cyp3A11 Protects Against Non-Steroidal Pain Analgesics Induced Acute Liver Damage in Sickle Cell Disease Mice.

Vats R, Ungalara R, Dubey R, Sundd P, Pradhan-Sundd T Cells. 2025; 14(3).

PMID: 39936985 PMC: 11817884. DOI: 10.3390/cells14030194.


Substance use disorder of equimolar oxygen-nitrous oxide mixture in French sickle-cell patients: results of the PHEDRE study.

Gerardin M, Rousselet M, Couec M, Masseau A, Aquizerate A, Authier N Orphanet J Rare Dis. 2024; 19(1):124.

PMID: 38500184 PMC: 10949610. DOI: 10.1186/s13023-024-03133-w.


The Associations Between Opioid Use Disorder and Healthcare-Related Outcomes in Vaso-occlusive Crisis.

Sanni A, Goble S, Gilbertson D, Johnson D, Linzer M J Gen Intern Med. 2024; 39(9):1666-1672.

PMID: 38499723 PMC: 11254892. DOI: 10.1007/s11606-024-08717-7.


Opioid Use Disorder: A Qualitative Exploratory Analysis of Potential Misunderstandings in Patients with Chronic Non-Cancer Pain.

Kufeld N, Weckbecker K, Michalak J, Hauser W, Petzke F, Scherbaum N J Pain Res. 2024; 17:873-885.

PMID: 38476877 PMC: 10929247. DOI: 10.2147/JPR.S445153.


Cannabis-Based Medicines and Medical Cannabis for Chronic Neuropathic Pain.

Petzke F, Tolle T, Fitzcharles M, Hauser W CNS Drugs. 2021; 36(1):31-44.

PMID: 34802112 PMC: 8732831. DOI: 10.1007/s40263-021-00879-w.